Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
17 studies found for:    Pulmonary Embolism | Open Studies | NIH, U.S. Fed
Show Display Options
Download search resultsDownload the search results for:
Pulmonary Embolism | Open Studies | NIH, U.S. Fed (17 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT
Conditions: Acute Kidney Injury;   Pulmonary Embolism;   Contrast-induced Nephropathy
Interventions: Diagnostic Test: V/Q imaging;   Diagnostic Test: Computed tomography scan
2 Recruiting Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
Conditions: Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolus
Interventions: Drug: Twice daily enoxaparin prophylaxis;   Drug: Real time dose adjustment
3 Recruiting Thrombosis Outcomes in Pediatric Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention:
4 Recruiting Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Pulmonary Embolism;   Renal Artery Stenosis;   Pulmonary Cancer
Interventions: Drug: Low Volume iso-osmolar non-ionic radio contrast medium;   Drug: Acetylcysteine Inhalation;   Drug: Sodium Bicarbonate Solution;   Procedure: 64-MDCT Scanning
5 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Condition: HIV
Intervention:
6 Not yet recruiting Apixaban in Preventing Secondary Cancer Related Blood Clots in Cancer Patients Who Have Completed Anticoagulation Therapy
Conditions: Deep Vein Thrombosis;   Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Pulmonary Embolism
Intervention: Drug: Apixaban
7 Recruiting Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Conditions: Deep Vein Thrombosis;   Malignant Neoplasm;   Portal Vein Thrombosis;   Pulmonary Embolism;   Renal Vein Thrombosis;   Venous Thromboembolism
Interventions: Drug: Apixaban;   Drug: Dalteparin;   Other: Questionnaire Administration
8 Recruiting A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Coagulopathies;   Pulmonary Embolism
Interventions: Genetic: Genotype-guided;   Other: Standard-of-Care
9 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
10 Recruiting A Randomized Trial of Induction Versus Expectant Management
Condition: Labor and Delivery
Intervention: Procedure: Elective Induction of Labor
11 Recruiting Cancer Associated Thrombosis and Isoquercetin (CAT IQ)
Conditions: Thromboembolism of Vein VTE in Colorectal Cancer;   Thromboembolism of Vein in Pancreatic Cancer;   Thromboembolism of Vein in Non-small Cell Lung Cancer
Intervention: Drug: Isoquercetin
12 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
13 Recruiting Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
Conditions: Thromboembolism;   Blood Coagulation Disorders;   Cardiovascular Disease;   Vascular Disease
Intervention: Other: Patient Self-Monitoring vs Anticoagulation Clinic
14 Recruiting Fatty Acid Regulation of Platelet Function in Diabetes
Conditions: Thrombosis;   Type 2 Diabetes Mellitus
Intervention: Other: omega-3 and -6 fatty acids and their 12-LOX oxylipins
15 Recruiting Physical Activity in Children at Risk of Post-thrombotic Syndrome (PACT)
Conditions: Post Thrombotic Syndrome;   Deep Vein Thrombosis
Interventions: Device: Fitbit;   Behavioral: 30-minute education session
16 Not yet recruiting Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Conditions: Deep Vein Thrombosis;   Post-Thrombotic Syndrome;   Venous Thrombosis
Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA);   Drug: Standard Anticoagulation Therapy
17 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Adenovirus;   Adrenal Insufficiency;   Airway Swelling;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Brain Swelling;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Edema;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Headaches;   Herpes Simplex Virus;   Hypertension;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Influenza;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Prophylaxis;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Stable Angina;   Thromboprophylaxis;   Thrombosis;   Treatment-resistant Schizophrenia;   Urinary Tract Infection;   Withdrawal
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:

Study has passed its completion date and status has not been verified in more than two years.